Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00660322 · ClinicalTrials.gov registry record · NA
Using the Telephone to Improve Care in Childhood Asthma
A NA study, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- Completed
- Registry status
- NA
- Development phase
- 362
- Enrollment target
NCT00660322 is a NA study that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 362 participants.
The verdict
NCT00660322, a NA study, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- COMPLETED
- Registry status
- NA
- Development phase
- 362 participants
- Enrollment target
Study Summary
Asthma is the most common chronic disease of childhood and a major cause of morbidity in the United States. If asthma symptoms are controlled, a child with asthma can stay well and lead a normal life. Daily use of inhaled steroids controls symptoms and reduces morbidity and emergent health care utilization in children with persistent asthma, and is safe for long-term use. However, inhaled steroids are underused in community asthma care. The Telephone Asthma Program (TAP) is a series of brief, telephone calls with a trained coach to help the parent manage the child's asthma care. The coach will teach self-management skills, help the parent to use the child's asthma medicines effectively, provide support and remind the parent to go for follow-up care with the pediatrician. We hypothesized that the Telephone Asthma Program will reduce the incidence of acute exacerbations of asthma that require emergent care, improve the quality of life of children with asthma and their parents, and increase the daily use of inhaled steroids in children with persistent asthma. We evaluated the Telephone Asthma Program in a randomized controlled trial involving 362 children aged 5 to 12 years old cared for by community pediatricians. Eligible children were randomized to the TAP program or usual care by their pediatrician.
Interventions
- BEHAVIORAL Telephone Asthma Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 362 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00660322
The ClinicalTrials.gov registry entry for NCT00660322 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 362 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agency for Healthcare Research and Quality (AHRQ), which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telephone Asthma Program is the first listed.
NCT00660322 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00660322 about?
NCT00660322 is a clinical study titled "Using the Telephone to Improve Care in Childhood Asthma". Asthma is the most common chronic disease of childhood and a major cause of morbidity in the United States. If asthma symptoms are controlled, a child with asthma can stay well and lead a normal life. Daily use of inhaled steroids controls symptoms and reduces morbidity and emergent health care util...
What is the current status of trial NCT00660322?
This trial is currently completed. It is a NA study. The enrollment target is 362 participants. The study started on 2004-01. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00660322?
The interventions under investigation include: Telephone Asthma Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00660322?
This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.